IP Library › Granted Patent US 9,365,610
Granted Patent B2
US 9,365,610 · App. 14/707,876 · Granted Jun 14, 2016

Asymmetric ionizable cationic lipid for RNA delivery

Inventors: Joseph E. Payne (San Diego, CA); Padmanabh Chivukula (San Diego, CA); David Webb (Oceanside, CA)
Assignee: Arcturus Therapeutics, Inc.
C07J41/0055A23D9/013C07C235/12C07C237/12C07C271/22C07C333/04C12N15/111A61K9/1075A61K9/1272C12N2310/14C12N2320/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,365,610
App. No.
14/707,876
Granted
Jun 14, 2016
Kind
B2
Abstract

What is described is a compound of formula I wherein R 1 consists of a linear or branched alkyl consisting of 1-18 carbons, an alkenyl or alkynyl consisting of 2 to 12 carbons, or a cholesteryl; R 2 consists of a linear or branched alkyl or an alkenyl consisting of 1 to 18 carbons; L 1 consists of a linear alkyl consisting of 5 to 9 carbons or, when R 1 consists of a cholesteryl then L 1 consists of a linear alkylene or alkenyl consisting of 3 to 4 carbons; X 1 consists of —O—(CO)— or —(CO)—O—; X 2 consists of S or O; L 2 consists of a bond or a linear alkylene of 1 to 6 carbons; R 3 consists of a linear or branched alkylene with 1 to 6 carbons; and R 4 and R 5 are the same or different, each consisting of a linear or branched alkyl of 1 to 6 carbons; or a pharmaceutically acceptable salt thereof.

Claims (27)

1. A compound of formula I

wherein

R 1 consists of a linear or branched alkyl consisting of 1 to 20 carbons, an alkenyl or alkynyl consisting of 2 to 12 carbons, or a cholesteryl;

R 2 consists of a linear or branched alkyl consisting of 1 to 20 carbons or an alkenyl consisting of 2 to 20 carbons;

L 1 consists of a linear alkyl consisting of 3 to 9 carbons or, when R 1 consists of a cholesteryl then L 1 consists of a linear alkylene or alkenyl consisting of 3 to 4 carbons;

X 1 consists of —O—(CO)— or —(CO)—O—;

X 2 consists of S or O;

L 2 consists of a bond or a linear alkylene of 1 to 6 carbons;

R 3 consists of a linear or branched alkylene with 1 to 6 carbons; and

R 4 and R 5 are the same or different, each consisting of a linear or branched alkyl of 1 to 6 carbons;

or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1 , wherein X 1 consists of —O—(CO)—.

3. The compound of claim 1 , wherein X 2 consists of S.

4. The compound of claim 1 , wherein R 3 consists of ethylene.

5. The compound of claim 1 , wherein R 3 consists of n-propylene or isopropylene.

6. The compound of claim 1 , wherein R 4 and R 5 each consist of methyl, ethyl, or isopropyl.

7. The compound of claim 1 , wherein L 2 consists of a bond.

8. The compound of claim 1 , wherein L 2 consists of a methylene.

9. The compound of claim 1 , wherein R 1 and R 2 each consist of branched alkyl.

10. The compound of claim 1 , wherein R 2 consists of an alkyl.

11. The compound of claim 1 , wherein R 1 and R 2 each consist of 19 or 20 carbon atoms.

12. The compound of claim 1 , wherein R 1 or R 2 each consist of 13 or 14 carbon atoms.

13. The compound of claim 1 , wherein L 2 consists of a methylene, R 3 consists of ethylene, X 1 consists of —O—(CO)—, X 2 consists of S, and R 4 and R 5 each consist of methyl.

14. The compound of claim 1 , wherein L 2 consists of a bond, R 3 consists of ethylene, X 1 consists of —O—(CO)—, X 2 consists of S, and R 4 and R 5 each consist of methyl.

15. The compound of claim 1 , wherein L 2 consists of a bond, R 3 consists of n-propylene, X 1 consists of —O—(CO)—, X 2 consists of S, and R 4 and R 5 each consist of methyl.

16. The compound of claim 1 , wherein L 2 consists of a bond, R 3 consists of isopropylene, X 1 consists of —O—(CO)—, X 2 consists of S, and R 4 and R 5 each consist of methyl.

17. The compound of claim 1 , selected from the group consisting of the compounds of formula ATX-A-1 to ATX-A-22

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME IN THE ASSIGNMENT PREVIOUSLY RECORDED ON REEL 036785 FRAME 0248. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF THE ENTIRE RIGHT, TITLE, AND INTEREST. Recorded Oct 24, 2016
From: PAYNE, JOSEPH E.; CHIVUKULA, PADMANABH
To: ARCTURUS THERAPEUTICS, INC.
Reel/Frame 040264/0232 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2015
From: PAYNE, JOSEPH E.; CHIVUKULA, PADMANABH; WEBB, DAVID
To: ARCTURUS THERAPEUTIC, INC.
Reel/Frame 036785/0248 →
Continuity (3)
Continuation In Part 14546105 · Nov 18, 2014
Provisional Application 61905724 · Nov 18, 2013
Related Publication 20150239926A1 · Aug 27, 2015